These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man. Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251 [TBL] [Abstract][Full Text] [Related]
12. A new role for the virtual crossmatch in kidney allograft reuse. Bryan CF; Abdulkarim B; Forster J; Nelson PW; Diederich D; Murillo D; Markham L Transplantation; 2010 Mar; 89(6):764-5. PubMed ID: 20308864 [No Abstract] [Full Text] [Related]
13. Anti-HLA class I reimmunization after one HLA semi-identical blood transfusion in non-naive patients on a waiting list for a first renal allograft. Masson D; Bayle F; Vichier C; Zaoui P; Vialtel P; Bensa JC Transplant Proc; 1998 Sep; 30(6):2854. PubMed ID: 9745596 [No Abstract] [Full Text] [Related]
14. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen. Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671 [TBL] [Abstract][Full Text] [Related]
15. Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab. Beimler JH; Morath C; Schmidt J; Ovens J; Opelz G; Rahmel A; Zeier M; Süsal C Transplantation; 2009 Mar; 87(5):668-71. PubMed ID: 19295310 [TBL] [Abstract][Full Text] [Related]
16. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor. Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498 [No Abstract] [Full Text] [Related]
17. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival. Mizutani K; Katoh N; Yamada S; Ono Y; Takeuchi N; Matsuura O; Ohshima S Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797 [No Abstract] [Full Text] [Related]
18. Application of Prastat ELISA in the determination of anti-HLA specificity for immunized patients awaiting kidney transplant: five years' experience. Buscaroli A; De Sanctis LB; Iannelli S; Stipo L; Bertuzzi V; Raimondi C; Mosconi G; Liviano D' Arcangelo G; Scolari MP; Stefoni S Transpl Int; 2000; 13 Suppl 1():S99-105. PubMed ID: 11111973 [TBL] [Abstract][Full Text] [Related]
19. Renal transplantation in 2016: Novel approaches to improve recipient and allograft outcomes. Malvezzi P; Rostaing L Nat Rev Nephrol; 2017 Jan; 13(2):73-74. PubMed ID: 28100905 [No Abstract] [Full Text] [Related]
20. Long-term results of spousal renal donor transplants with donor-specific blood transfusions. Miura S; Okazaki H; Sato T; Amada N; Ohashi Y; Sato K Transplant Proc; 2001; 33(7-8):3417-9. PubMed ID: 11750463 [No Abstract] [Full Text] [Related] [Next] [New Search]